44 related articles for article (PubMed ID: 38760405)
1. Nucleobindin 2 inhibits senescence in gastric carcinoma.
Ishibashi Y; Itoh T; Oguri Y; Hashimura M; Yokoi A; Matsumoto T; Harada Y; Fukagawa N; Hayashi M; Ono M; Kusano C; Saegusa M
Sci Rep; 2024 May; 14(1):11261. PubMed ID: 38760405
[TBL] [Abstract][Full Text] [Related]
2. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
[TBL] [Abstract][Full Text] [Related]
3. Nucleobindin-2 Promotes the Growth and Invasion of Glioblastoma.
Liu QJ; Lv JX; Liu J; Zhang XB; Wang LB
Cancer Biother Radiopharm; 2019 Nov; 34(9):581-588. PubMed ID: 31697592
[No Abstract] [Full Text] [Related]
4. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.
Qi Q; Sun Y; Yang Y; Liu Y
Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717
[TBL] [Abstract][Full Text] [Related]
5. MiR-30a-5p inhibits proliferation, migration and invasion of nasopharyngeal carcinoma cells by targeting NUCB2.
Li M; Wang Y; Zhao Q; Ma W; Liu J
Hum Exp Toxicol; 2021 Aug; 40(8):1274-1285. PubMed ID: 33567921
[TBL] [Abstract][Full Text] [Related]
6. Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma.
Nakagawa M; Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Konno R; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
Mol Oncol; 2023 Oct; 17(10):2168-2182. PubMed ID: 37539980
[TBL] [Abstract][Full Text] [Related]
7. Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma.
Kobayashi Y; Yokoi A; Hashimura M; Oguri Y; Konno R; Matsumoto T; Tochimoto M; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
Am J Pathol; 2023 Aug; 193(8):1116-1128. PubMed ID: 37169340
[TBL] [Abstract][Full Text] [Related]
8. PTEN overexpression and nuclear β-catenin stabilization promote morular differentiation through induction of epithelial-mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma.
Yokoi A; Minami M; Hashimura M; Oguri Y; Matsumoto T; Hasegawa Y; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Saegusa M
Cell Commun Signal; 2022 Nov; 20(1):181. PubMed ID: 36411429
[TBL] [Abstract][Full Text] [Related]
9. Nucleobindin-2/nesfatin-1 enhances the cell proliferation, migration, invasion and epithelial-mesenchymal transition in gastric carcinoma.
Ren L; Bao D; Wang L; Xu Q; Xu Y; Shi Z
J Cell Mol Med; 2022 Oct; 26(19):4986-4994. PubMed ID: 36065769
[TBL] [Abstract][Full Text] [Related]
10. Senescence and cancer - role and therapeutic opportunities.
Schmitt CA; Wang B; Demaria M
Nat Rev Clin Oncol; 2022 Oct; 19(10):619-636. PubMed ID: 36045302
[TBL] [Abstract][Full Text] [Related]
11. Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer.
Zhou L; Niu Z; Wang Y; Zheng Y; Zhu Y; Wang C; Gao X; Gao L; Zhang W; Zhang K; Melino G; Huang H; Wang X; Sun Q
Cell Death Discov; 2022 Jan; 8(1):13. PubMed ID: 35013121
[TBL] [Abstract][Full Text] [Related]
12. Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis.
De Blander H; Morel AP; Senaratne AP; Ouzounova M; Puisieux A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572787
[TBL] [Abstract][Full Text] [Related]
13. The Multifaceted Nature of Nucleobindin-2 in Carcinogenesis.
Skorupska A; Lenda R; Ożyhar A; Bystranowska D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073612
[TBL] [Abstract][Full Text] [Related]
14. Cancer statistics for the year 2020: An overview.
Ferlay J; Colombet M; Soerjomataram I; Parkin DM; Piñeros M; Znaor A; Bray F
Int J Cancer; 2021 Apr; ():. PubMed ID: 33818764
[TBL] [Abstract][Full Text] [Related]
15. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity.
Guillon J; Petit C; Toutain B; Guette C; Lelièvre E; Coqueret O
Cell Cycle; 2019 Oct; 18(19):2385-2397. PubMed ID: 31397193
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of gastric cancer: global trends, risk factors and prevention.
Rawla P; Barsouk A
Prz Gastroenterol; 2019; 14(1):26-38. PubMed ID: 30944675
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
